Metraipolis › archive › dc_8ff474695d53

SEMA3B is associated with disease activity and infliximab response in IBD patients but does not contribute to the development of intestinal inflammation in vivo — Europe PMC PMID:41716378

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41716378
DOI
10.3389/fimmu.2026.1677130
License (as archived)
solo-consultazione
Archived
2026-11-06T03:36:20.376Z
SHA-256 of the archived text
64322e1052e023ffce3943d3b48eba28024b9c12efafa3f0d179dcab472b688f
Stable URL of this page
https://metraipolis.com/documento/dc_8ff474695d53

How to cite

SEMA3B is associated with disease activity and infliximab response in IBD patients but does not contribute to the development of intestinal inflammation in vivo — Europe PMC PMID:41716378 — Europe PMC (en), https://europepmc.org/article/MED/41716378 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ff474695d53 (Metraipolis archive dc_8ff474695d53, sha256 64322e1052e023ffce3943d3b48eba28024b9c12efafa3f0d179dcab472b688f)
BibTeX
@misc{dc8ff474695d53,
  title = {SEMA3B is associated with disease activity and infliximab response in IBD patients but does not contribute to the development of intestinal inflammation in vivo — Europe PMC PMID:41716378},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41716378},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ff474695d53; sha256 64322e1052e023ffce3943d3b48eba28024b9c12efafa3f0d179dcab472b688f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716378. Agents can read the archived copy with the MCP tool read_document.